DoD Gulf War Illness Clinical Trial Award

Funding Opportunity Number: W81XWH-15-GWIRP-CTA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Oct 29, 2015Award Ceiling: $0Expected Number of Awards: 1Creation Date: May 14, 2015Funding Opportunity Description: The FY15 GWIRP is offering two award mechanisms to evaluate potential interventions for GWI: the Clinical Trial Award and the Innovative Treatment Evaluation Award (ITEA). The Clinical Trial Award, described in this Program Announcement/Funding Opportunity, is intended to support larger, more definitive (Phase II-III, U.S. Food and Drug Administration [FDA] device class I-III) clinical trials. In contrast, the ITEA supports the initial evaluation of a treatment or intervention in smaller, early phase or pilot clinical trials (Phase 0, I, or I/II), and does not require preliminary data. For information about the ITEA, see http://cdmrp.army.mil/funding/gwirp.shtml. The Clinical Trial Award mechanism was first offered in FY08. Since then, 14 Clinical Trial Award applications were received, and 4 were recommended for funding. The Clinical Trial Award supports execution of clinical trial...
Source: Grants.gov - Category: Research Tags: Science and Technology and other Research and Development Source Type: funding